Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges ...

HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

HeartFlow recently filed a Form S-1 with the SEC to confirm its intent to complete an initial public offering (IPO) and go ...

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

The U.S. IPO market is witnessing a renewed vigor as investors return following months of sluggish activity triggered by ...

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...

Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis ...

Heartflow's numerous presentations at SCCT, demonstration of new Plaque Analysis technology, and recognition of the DECIDE study by the SCCT scientific community all underscore Heartflow's ...

MOUNTAIN VIEW, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced it will present new data and technology for ...

In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...